Research suggests that astaxanthin, as part of a multi-ingredient nutraceutical combination, may offer some antioxidant-related support based on limited preliminary evidence. The available evidence here consists of one small retrospective observational study examining a proprietary blend rather than astaxanthin in isolation, which reported faster symptom resolution in patients receiving the combination alongside standard care compared to standard care alone. Because the studied product contained multiple ingredients, it is not possible to attribute any observed effects specifically to astaxanthin, and the non-randomized, retrospective design with a small sample size significantly limits the strength of any conclusions. One additional study was not available for review, meaning the current evidence base for this specific application is quite narrow and should be interpreted with considerable caution.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Evolution of COVID-19 patients treated with a combination of nutraceuticals t... | Other | 2020 | Supports | 90 |
| Comparative genomics of a novel<i>Erwinia</i>species associated with the High... | Other | 2023 | Neutral | 85 |